DNA Methylation in Ovarian Tumors—a Comparison Between Fresh Tissue and FFPE Samples

• Published in: Reproductive sciences (Thousand Oaks, Calif.) Vol. 28; no. 11; pp. 3212 - 3218
• Main Authors: Oliveira, Douglas V.N.P., Hentze, Julie, O’Rourke, Colm J., Andersen, Jesper B., Høgdall, Claus, Høgdall, Estrid V.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.11.2021
• Subjects: Cohort Studies; DNA Methylation - physiology; Embryology; Epigenomics - methods; Female; Formaldehyde - administration & dosage; Gene Expression Profiling - methods; Gynecologic Oncology: Short Communication; Humans; Medicine; Medicine & Public Health; Obstetrics/Perinatology/Midwifery; Ovarian Neoplasms - genetics; Ovarian Neoplasms - metabolism; Ovarian Neoplasms - pathology; Paraffin Embedding - methods; Reproductive Medicine; Tissue Fixation - methods; High throughput; DNA methylation; Fresh tissue; FFPE; Ovarian cancer
• ISSN: 1933-7191; 1933-7205
• DOI: 10.1007/s43032-021-00589-0

Among women, ovarian cancer (OC) is one of the most severe forms of malignancy, accounting for a low 5-year survival rate, of approximately 52%. Early symptoms are unspecific and hence hard to detect. The origin of OC and its subtypes are still unclear, underlying the need for efficient diagnostic biomarkers. In that regard, epigenetics studies are emerging in cancer diagnostics, with encouraging outcomes. Among them, DNA methylation profiling has shown that the origins of the cancer epigenome are associated with molecular factors that are crucial to carcinogenesis, such as regulation of oncogenes and tumor suppressors. Furthermore, those events have been detected in abnormal cell morphology before neoplastic formation, indicating its potential crucial use in the OC diagnostics in the future. Nonetheless, studies are limited, and whether methylation analysis can be performed optimally in formalin-fixed paraffin-embedded (FFPE) preparations of OC cases is still elusive. In the present report, we investigated the performance of DNA methylation analysis in FFPE samples, compared to their matched fresh frozen tissue in a small cohort of OC samples. We found that the overall DNA methylation profile in FFPE tissue showed high concordance to that found in fresh frozen tissue, and accounting for the small cohort size, the differentially methylated sites found primarily in frozen tissue, compared to benign samples, were also reproducible in FFPE. Overall, by using samples from our current clinical setting of tissue preservation, these preliminary observations might provide insights into the clinical use of FFPE tissues in methylation studies without critically compromising the outcome.